Financials in USD. Standardized financial statements.
A compact view of how Liminal BioSciences Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $401,000 | $643,000 | $3.32M | $4.90M | $47.37M | $39.12M | $16.39M | $24.53M | $23.01M | $20.64M |
| Revenue Growth? | -37.6% | -80.6% | -32.4% | -89.6% | +21.1% | +138.6% | -33.2% | +6.6% | +11.5% | 0.0% |
| Cost of Revenue? | $0 | $0 | $2.03M | $2.76M | $38.00M | $10.15M | $6.76M | $8.22M | $7.01M | $6.59M |
| Gross Profit? | $401,000 | $643,000 | $1.28M | $2.14M | $9.37M | $28.97M | $9.63M | $16.32M | $15.99M | $14.05M |
| Gross Margin? | +100.0% | +100.0% | +38.7% | +43.7% | +19.8% | +74.1% | +58.8% | +66.5% | +69.5% | +68.1% |
| Operating Expenses? | $33.16M | $50.27M | $95.38M | $120.40M | $123.20M | $152.32M | $117.38M | $66.83M | $48.10M | $27.14M |
| Operating Income? | -$32.98M | -$49.56M | -$94.27M | -$210.63M | -$113.54M | -$123.05M | -$107.38M | -$50.14M | $2.58M | -$10.10M |
| EBITDA? | -$31.86M | -$45.21M | -$105.17M | -$200.72M | -$108.08M | -$118.47M | -$104.13M | -$47.70M | $4.27M | -$9.23M |
| Income Before Tax | -$29.44M | -$44.95M | -$122.34M | -$234.46M | -$257.92M | -$134.79M | -$116.89M | -$61.92M | -$480,000 | -$17.27M |
| Income Tax Expense | -$525,000 | $118,000 | -$201,000 | -$237,000 | -$20.02M | -$14.75M | -$6.22M | -$5.14M | -$3.06M | $131,000 |
| Net Income? | -$28.92M | -$45.06M | -$122.14M | -$234.22M | -$195.37M | -$109.73M | -$100.81M | -$50.96M | $5.94M | -$16.49M |
| EPS? | $-341.80 | $-532.66 | $-1443.70 | $-2768.61 | $-2359.49 | $-1378.53 | $-1684.64 | $-892.74 | $100.00 | $-339.91 |
| Diluted EPS? | $-9.32 | $-14.94 | $-49.97 | $-145.82 | $-2359.49 | $-1378.53 | $-1684.64 | $-892.74 | $100.00 | $-339.91 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality